Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary
S

Sucroferric Oxyhydroxide

Availability of ACE Drug Guidance

Yes

Biologics Drug Information Overview

No

Subsidy Information and Financing Scheme

Medical Assistance Fund

Active ingredients: Ferric Salts | Iron Salts

General information

Subsidy Information and Financing Scheme

[MAF] Sucroferric oxyhydroxide Chewable Tablet 500 mg

  1. Treatment of hyperphosphataemia in patients with end-stage renal disease on haemodialysis or peritoneal dialysis who have persistent hyperphosphataemia despite optimising treatment with calcium-based phosphate binders, or who are unable to tolerate calcium-based phosphate binders due to hypercalcaemia.

View legend

Drug Guidance for Subsidy

16/09/2025 Sucroferric oxyhydroxide for treating hyperphosphataemia in patients with end-stage renal disease on dialysis

The Ministry of Health’s Drug Advisory Committee has recommended:

  • Sucroferric oxyhydroxide 500 mg chewable tablet for treating hyperphosphataemia in patients with end-stage renal disease on haemodialysis or peritoneal dialysis who have persistent hyperphosphataemia despite optimising treatment with calcium-based phosphate binders, or who are unable to tolerate calcium-based phosphate binders due to hypercalcaemia.

Funding status

[R] Sucroferric oxyhydroxide 500 mg chewable tablet is recommended for inclusion on the Medication Assistance Fund (MAF) for the abovementioned indication from 1 November 2025.

View legend

General Availability in Public Healthcare Institution

Note:

General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.

Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration

Availability information

Formulation

Public Healthcare Institution

Chewable Tablet 500 mg

  1. Changi General Hospital

  2. Ng Teng Fong General Hospital

  3. National University Hospital

  4. Sengkang General Hospital

  5. Singapore General Hospital

  6. Tan Tock Seng Hospital

Registered Product(s) Information

Clinical and product info

Clinical info

Product Info

Information under the Indication, Dosage and Contraindication sections are extracted from the relevant Package Insert/Patient Information Leaflet of the product available on HSA Infosearch. For more information, please refer to the product's Package Insert/ Patient Information Leaflet available on HSA Infosearch.

The information provided is for informational purposes only, and is not exhaustive. The information provided is not a substitute for professional medical advice. Please consult a qualified healthcare provider for any medical advice.

Information available here are product details as registered with the HSA. As this website is updated monthly, please refer to HSA Infosearch for the most updated product information.

Oral

* Clinical information is available for this product.

Back to top